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Abstract  1 
RNA modifications play a fundamental role in cellular function. Pseudouridylation, the most abundant RNA 2 
modification, is catalysed by the H/ACA small ribonucleoprotein (snoRNP) complex that shares four core 3 
proteins, dyskerin (DKC1), NOP10, NHP2 and GAR1. Mutations in DKC1, NOP10 or NHP2 cause Dyskeratosis 4 
Congenita (DC), a disorder characterized by telomere attrition. Here we report a novel phenotype 5 
comprising nephrotic syndrome, cataracts, sensorineural deafness, enterocolitis and early lethality in two 6 
pedigrees; males with DKC1 p.Glu206Lys and in two children with homozygous NOP10 p.Thr16Met. 7 
Females with heterozygous DKC1 p.Glu206Lys developed cataracts and sensorineural deafness, but 8 
nephrotic syndrome in only one case of skewed X-inactivation. We found telomere attrition in both 9 
pedigrees but no mucocutaneous abnormalities suggestive of DC. Both mutations fall at the dyskerin-10 
NOP10 binding interface in a region distinct from those implicated in DC, impair the dyskerin-NOP10 11 
interaction and disrupt the catalytic pseudouridylation site. Accordingly, we found reduced pseudouridine 12 
levels in the rRNA of the patients. Zebrafish dkc1 mutants recapitulate the human phenotype and show 13 
reduced 18S pseudouridylation, ribosomal dysregulation and a cell-cycle defect in the absence of telomere 14 
attrition. We therefore propose that this novel human disorder is the consequence of defective snoRNP 15 
pseudouridylation and ribosomal dysfunction.  16 





Significance Statement 1 
Isomerization of uridine to pseudouridine is the most abundant RNA modification in eukaryotes. 2 
In ribosomal (r)RNA, this process of pseudouridylation is catalyzed by a ribonucleoprotein complex. 3 
Mutations of this complex were formerly identified in mucocutaneous and developmental abnormalities, 4 
resulting from telomere attrition. Here we identified complementary mutations in two proteins of the 5 
complex, affecting the highly conserved pseudouridylation catalytic site, associated with a novel 6 
phenotype characterized by renal, ocular, intestinal and auditory features, alongside reduced 7 
pseudouridine in rRNA and telomere attrition. Using a zebrafish model, we provide supporting evidence 8 
that this phenotype results from ribosomal dysfunction arising from a pseudouridylation defect of rRNAs. 9 
Together this describes a novel phenotype associated with the disruption of the most abundant RNA 10 
modification.  11 





Main text 1 
Pseudouridylation, the isomerization of uridine (U) to pseudouridine (), is the most common 2 
modification of RNA. It can be catalyzed by single protein pseudouridine synthases (PUSs) that act 3 
independently to recognize the substrate uridine or by the H/ACA small nucleolar ribonucleoprotein 4 
(snoRNP) complex (1, 2). Each complex is composed of a unique guide RNA and four core proteins, NOP10, 5 
NHP2, GAR1 and the catalytically active dyskerin (DKC1) (3). Knockdown of dyskerin results in a >50% 6 
reduction in rRNA pseudouridylation, indicating the primary role of the H/ACA snoRNP complex in the 7 
pseudouridylation of rRNAs (4). 8 
 9 
Through its association with the telomerase RNA, TERC, the H/ACA snoRNP complex also plays a critical 10 
role in telomere synthesis (5). It is this function which links the snoRNPs (DKC1 (6, 7), NHP2 (8, 9) and 11 
NOP10 (10)) to the disease Dyskeratosis Congenita (DC, OMIM: 305000, 224230, 613987), characterised 12 
by mucocutaneous abnormalities and bone marrow failure and its more severe form, Hoyeraal-13 
Hreidarsson syndrome (HH) with intrauterine growth retardation, microcephaly, cerebellar hypoplasia and 14 
in rare cases enteropathy. The role of defective telomere biogenesis in DC has been further corroborated 15 
by the identification of mutations in other genes TERT, TERC, TINF2 and RTEL1 (7, 11-14), which are 16 
implicated in telomere maintenance but not in pseudouridylation. Indeed, progressive telomere attrition 17 
in the autosomal dominant TERT or TERC-related DC results in disease anticipation (15, 16) and wild-type 18 
(WT) offspring of telomerase deficient mice with shortened telomeres develop an occult DC phenotype 19 
(17). The exhaustion of cellular renewal in DKC1-linked DC is rescued by the overexpression of TERC, 20 
reflecting the driving role of TERC level in the pathogenesis (18). 21 
While human disorders associated with PUS-mediated pseudouridylation defects have been described (19-22 
21), a human phenotype related to defective H/ACA snoRNP complex-mediated pseudouridylation has 23 





been lacking. Herein, we describe a novel human phenotype and early lethality in two unrelated pedigrees. 1 
Using linkage analysis and whole exome sequencing, novel mutations within DKC1 and NOP10 were 2 
identified in two families. A combination of structural and in vivo analysis demonstrates that a 3 
pseudouridylation defect of rRNA is what drives the distinction of this novel phenotype from classic DC.  4 
 5 
The two unrelated pedigrees presented with an infantile-onset disorder characterized by steroid-resistant 6 
nephrotic syndrome, cataracts (prior to steroid treatment), sensorineural deafness and enterocolitis 7 
(Table 1, Figure 1). In the first pedigree, the disorder segregated in an X-linked pattern (FamA, Figure 1v) 8 
and in an autosomal recessive mode in the second (FamB, Figure 1x). All six affected males in FamA and 9 
the two affected females in FamB died in early childhood (Table 1). To identify the causative genetic loci, 10 
we performed linkage analysis in both families (Figure 1w, y). A single locus of 5.1 Mb at the telomeric end 11 
of the X chromosome long arm segregated with the disease in FamA, assuming that the causative mutation 12 
led to germline mosaicism in I:2. By sequencing the locus-specific coding regions of the affected IV:14 and 13 
the haploidentical but unaffected II:9 males, we found a single difference in the sequences: a point 14 
mutation in DKC1 (c.616 G>A, p.Glu206Lys; Figure S1a). We considered this variant to be causative as it 15 
appeared de novo, segregated with disease in generation II corresponding to the assumed maternal 16 
germline mosaicism (Figure 1v), affected a universally conserved glutamic acid (replaced by aspartic acid 17 
in some invertebrates, Figure S1b) and the resulting change to lysine was predicted to be pathogenic by 18 
Mutation Taster, Polyphen-2 and SIFT. This variant was absent in gnomAD and in 555 alleles of 368 19 
ethnically matched controls. The mutation is thus classified as pathogenic based on the ACMG/AMP 20 
criteria with evidence levels PS2, PM1-2, PP1-3 (22). 21 
In FamB, whole exome sequencing and linkage analysis identified a mutation in NOP10 (c.47C>T, 22 
p.Thr16Met; Figure S1a) within a homozygous region of 2.6 Mb in 15q14 (Figure 1y). The affected 23 





threonine is conserved down to yeast (Saccharomyces cerevisiae, Figure S1b), the change to methionine 1 
has not been found in the general population and was predicted as pathogenic by MutationTaster and 2 
SIFT. This variant is therefore also classified as likely pathogenic based on the ACMG/AMP criteria 3 
with evidence levels PM1-2, PP1 and PP3 (22). 4 
 5 
There was minimal overlap between the novel DKC1 p.Glu206Lys- and NOP10 p.Thr16Met-related 6 
phenotype (Figures 1l and 2h) and the developmental anomalies of HH or the diagnostic mucocutaneous 7 
triad of DC (dyskeratosis, leukoplakia and nail dystrophy) (7); though the latter typically appear between 8 
the ages of five and ten years (23), beyond the lifetime of the children presented here (Table 1). 9 
Furthermore, with the exception of enterocolitis, cerebellar hypoplasia and progressive bone marrow 10 
failure found in a subset of the affected children (Table 1), the prominent features of this novel phenotype 11 
(Figure 1d-u) have not been reported in DC or HH. In contrast to the X-linked recessive transmission of 12 
DKC1-linked DC (24), females heterozygous for dyskerin p.Glu206Lys also developed cataracts and hearing 13 
impairment, necessitating artificial lens implantation and hearing aid in the second decade of life (Figure 14 
1, Table 1), as well as maxillary and mandibular hypoplasia, pigmentary retinopathy, microphthalmia, 15 
pineal hypoplasia, mild cerebellar vermis atrophy and failure to thrive (Figures 1 and S2, Table 1). 16 
Pigmentary retinopathy was diagnosed in three heterozygous females (III:3, IV:4 and IV:12) resulting in no 17 
loss of visual acuity, but a flat electroretinogram. The index female in FamA (IV:4) developed a phenotype 18 
comparable to that of the males, requiring a hearing device at the age of one year, cataract operation at 19 
five and renal replacement therapy by six years. However, no enterocolitis or bone marrow failure 20 
presented (up to her present age of 15 years). We found by allele-specific qPCR a highly skewed X-21 
inactivation in skin cells and fibroblasts explaining her severe phenotype (Figure 2g). In accordance with 22 





the survival advantage of the cells expressing the WT allele in DKC1-linked DC (25, 26), her X-inactivation 1 
in leukocytes tended to be skewed towards the mutant allele by the second decade of life (Figure 2g).  2 
 3 
We measured telomere length by Southern blot, monochrome multiplex quantitative PCR (MM-qPCR) and 4 
flow- fluorescent in-situ hybridization (FISH) and found the telomeres to be shortened in both families 5 
(Figure 2a-f), as with DC (27). This indicates that the identified mutations reduce the telomerase activity 6 
of the H/ACA snoRNP complex similarly to other DC-related DKC1 and NOP10 mutations. However, as the 7 
novel phenotypic features could not be attributed to telomere shortening, we aimed to unravel what 8 
distinguishes the effect of these novel mutations from those associated with DC.  9 
 10 
We first conducted structural analyses of the snoRNP complex. Dyskerin, NOP10 and NHP2 directly 11 
associate with the guide H/ACA small nucleolar RNA (snoRNA) (Figure 3a), which binds and orientates the 12 
substrate RNA, specifically its target uridine, within the active pocket of dyskerin. Previously described 13 
cases of DC are associated with mutations that mostly concern amino acids implicated in the binding of 14 
the guide snoRNA (1, 28). The majority of these mutations are thus located at sites that interact with the 15 
guide RNA,  such as the N- or C-termini of dyskerin (or Ser121 of the TruB domain), the Arg34 residue of 16 
NOP10 – reported in the single family with a NOP10 mutation (10) – or Arg61, Pro87 and Val126 of NHP2 17 
(Figure 3a; spheres); with the only known exceptions of R158 and S280 of dyskerin. In contrast, dyskerin 18 
Glu206 and NOP10 Thr16 are located at the dyskerin-NOP10 interface, remote from both RNA components 19 
(Figure 3a). We found the subcellular localization of the p.Glu206Lys dyskerin to be preserved, similar to 20 
the most common DC-related mutation, p.Ala353Val (Figure S3). Reciprocal co-immunoprecipitation 21 
analysis demonstrated that the complex formation capacity of p.Glu206Lys dyskerin-NOP10 and 22 
p.Thr16Met NOP10-dyskerin (Figures 3b) was maintained. In native patient protein, where we observed a 23 





reduced level of p.Thr16Met NOP10, suggesting a possible effect on protein stability, the binding 1 
interaction with dyskerin was still maintained (Figure S4). However, both mutations do alter the hydrogen-2 
bonding between dyskerin and NOP10, reflected in their dissociation constant, as reported by pressure 3 
tuning fluorescence spectroscopy (Figure 3c-f) and the conformational changes (Figure 3g) seen in 4 
molecular dynamics (MD) simulations (Figure S5). MD simulations of the WT and two mutant states of the 5 
human snoRNP complex (containing all four protein components, the guide- and substrate-RNA chains) 6 
were carried out using homology modeling. The complex was modeled based on crystal-defined structures 7 
of full and partial H/ACA snoRNPs from Pyrococcus furiosus and Saccharomyces cerevisiae, as the structure 8 
of the human enzyme complex has not yet been determined. Significantly, comparison of the MD derived 9 
structures of the WT and mutant complexes revealed that structural changes at the dyskerin/NOP10 10 
interaction surface result in a rearrangement of the pseudouridylation pocket (which sits over 20 Å away), 11 
detaching the catalytic Asp125 of dyskerin from the uridine of the bound substrate RNA (Figure 3h). Two 12 
different interaction paths can be found between the mutation sites and the catalytic core: one connecting 13 
Tyr15 of NOP10 to Arg248 of dyskerin, a residue that plays a role in fixing the phosphate group of the 14 
uridine substrate (via the Tyr15(NOP10)Arg247(dyskerin) Hbond) (29) and another intricate network of 15 
H-bonds and hydrophobic interactions linking the 16-18 segment of NOP10 and the loop 122-131 carrying 16 
the catalytic Asp125 of dyskerin: Thr16 and Lys18 of NOP10 form H-bonds with Glu206 and Glu208 of 17 
dyskerin, the latter of which is also H-bound to Arg211 (dyskerin). This residue is stacked against Phe2 of 18 
NOP10 that reaches into a pocket also comprising dyskerin Arg158, Leu213, Gln244 and Glu245. Glu245 is 19 
H-bond to His31 of NOP10, a residue also coordinated by Thr129 of dyskerin, which is located in the loop 20 
carrying the active Asp125. This gear-wheel like contact surface of the two proteins allows for 21 
communication between far lying sites; the subtle changes elicited by the mutations at the 22 
dyskerin/NOP10 interface therefore have the capacity to influence both substrate binding and catalysis in 23 





the substrate binding pocket of dyskerin. Together, these findings indicate that both dyskerin p.Glu206Lys 1 
and NOP10 p.Thr16Met alter the pseudouridylation capacity of the snoRNP complex, suggesting the 2 
pathogenic commonality underlying this phenotype. 3 
 4 
As both mutations act by disrupting the catalytic center of dyskerin, we aimed to gain greater insight into 5 
the resulting pathogenesis and generated mutations in zebrafish dkc1 targeting different regions of the 6 
gene (elu1 and elu8, Figure S6). In situ hybridisation characterized the expression of dkc1 during zebrafish 7 
development, confirming its ubiquitous expression up to 12 hours post fertilization (dpf), with strong 8 
expression at sphere stage, suggesting the presence of a maternal component (Figure S7). Both elu1 and 9 
elu8 homozygous null dkc1 mutants die at five dpf with a phenotype equivalent to the human phenotype. 10 
We confirmed the specificity of the null phenotype with a translation-blocking anti-sense morpholino 11 
(Figure S6).  12 
 13 
Ocular sections of dkc1elu1/elu1 larvae showed opaque lenses due to the persistence of nucleated fiber cells 14 
akin to zebrafish cataract models (30) and a high abundance of cells with a neuroepithelial morphology, 15 
characteristic of progenitor cells (Figure 4a). We observed increased staining for proliferation markers in 16 
the retina and optic tecta (Figure 4a), areas with high dkc1 expression (Figure S7), indicative of a cell-cycle 17 
defect. Inner ear development was impaired, with the cylindrical projections from the otocyst walls 18 
remaining unfused and the intestinal compartments of the gut undifferentiated (Fig 4b). Indeed, several 19 
tissues showed reduced expression of differentiation markers in dkc1elu1/elu1 larvae (Figure 4d). 20 
Development of the pronephros was severely hypoplastic, with reduced Wt1-positive podocyte number 21 
(Figure 4b), though no increased filtration of 500kDa FITC-dextran was observed at this stage (Figure S8a). 22 
A hematopoietic defect was also observed (Figures 4d and S8c), as described in previous dkc1 and nop10 23 





null zebrafish models (31, 32). Lack of dkc1 also caused defective jaw-cartilage development (Figure S8b) 1 
and a disorganized pineal gland (Figure 4c), features of the female DKC1 p.Glu206Lys patients (Figure S2).  2 
 3 
Null mutants showed rescue with zygotic injection of WT human DKC1 mRNA (Figures 4e and S6d). A far 4 
weaker rescue was achieved by DKC1 p.Glu206Lys mRNA, indicating its pathogenicity with some limited 5 
function (Figures 4e and S6d). A hypomorphic (elu2) allele was also generated (Figure S6a): these 6 
dkc1elu2/elu2 fish were viable, albeit with significant growth retardation (Figure 5j). The combined analysis 7 
of two null mutants replicating the human phenotype, a morphant and the limited phenotypic rescue with 8 
DKC1 p.Glu206Lys mRNA provides strong support for the phenotypic relevance of this model.  9 
 10 
Telomere biogenesis in the zebrafish is similar to that of humans (33). We observed no telomere 11 
shortening in the dkc1elu1/elu1 animals (Figure 5a), similar to nop10 or nola1 (GAR1) deficient larvae (31, 32). 12 
Our structural analysis, demonstrating the effect of p.Glu206Lys and p.Thr16Met on the pseudouridylation 13 
pocket, suggested a potential role for the defective pseudouridylation of the rRNA and consequential 14 
ribosomal dysfunction. The abundance of processed 18S rRNA was low in dkc1elu1/elu1 larvae (Figure 5b), as 15 
with previous findings in nop10 and nola1 (GAR1) mutants and dkc1 morphants (31, 32). This is in 16 
accordance with the reduced pseudouridylation of 18S rRNA in dkc1elu1/elu1 and dkc1elu8/elu8 larvae (Figure 17 
5c), as well as in the PBMCs of patient IV:3, FamB (Figure 5d), as detected by Immuno-Northern blot. A 18 
pseudouridylation defect was also apparent in the decreased /U ratio (detected by HPLC-MS) in the 19 
PBMCs of the index female with skewed X-inactivation (FamA, IV:4) (Figure 5e). In contrast, 20 
pseudouridylation of 18S rRNA in the fibroblasts and the /U ratio in the skin of these patients was not 21 
different from that of controls (Figure S9), suggestive of the tissue-specific effect of DKC1-mutations on 22 
pseudouridylation (34). The difference in the pseudouridylation defect may reflect contribute to the 23 





differential survival advantage of the mutant allele in fibroblasts and PBMCs in the index girl (FamA, IV:4) 1 
(Figure 2g).  2 
Transcriptomic analysis of the dkc1elu1/elu1 larvae also highlighted defects in ribosome biogenesis (Figure 5f) 3 
and the mutant phenotype was recapitulated in WT embryos treated with the translational inhibitor 4 
cycloheximide (35) (Figure S6c). This observed phenotype is also highly reminiscent to that described in 5 
homozygous mutants of genes encoding ribosomal proteins (31, 36-38). Together these results suggest 6 
ribosomal dysfunction to be a main driver of the phenotype.  7 
 8 
In accordance with previous zebrafish models of ribosomopathies (31, 32, 38), we found dysregulated 9 
Tp53 expression in mutants. Western blot analysis suggested the stabilization and accumulation of Tp53 10 
protein in mutants (Figure 5g), in line with previous results from disrupted ribosomal biogenesis models 11 
(39). Further analysis however, showed the transcription of the full-length isoform to be down-regulated 12 
and the truncated, anti-apoptotic 113p53 isoform up-regulated (Figure 5h). The latter isoform inhibits 13 
the classic Tp53-response in zebrafish (40), fitting with the sustained proliferative state we describe (Figure 14 
4a). However, the dkc1elu1/elu1 phenotype was not rescued on a tp53-null background (Figure 5i), with the 15 
exception of a partial rescue of hematopoiesis (Figure S8c), as has been previously reported in dkc1 (31) 16 
and nop10 (32) deficient larvae. This indicates that the major phenotypic features observed upon loss of 17 
Dkc1 function are not mediated by Tp53.  18 
 19 
Previous studies suggest a more fundamental role for the snoRNP complex than that of hematopoiesis or 20 
telomere maintenance alone: Dkc1-deficient mice die in utero (26) and nop10 and nola1/GAR1 mutant 21 
and dkc1 morphant zebrafishes die at 5-10 dpf, all with normal telomere length (32, 33). Though reduced 22 
dyskerin expression in mice (41) and some DC-related DKC1 mutations (34) were shown to affect rRNA 23 





pseudouridylation, other DC-related DKC1 mutations did not (18, 42), or exerted only a subtle effect (4). 1 
Here we show that mutations affecting the dyskerin-NOP10 interaction and the pseudouridylation pocket 2 
of the H/ACA snoRNP complex cause a novel phenotype with early lethality. Several non-classical 3 
phenotypic features have been described in telomere biology disorders (43). This phenotype presents the 4 
novel features of nephrotic syndrome and cataracts which have not yet reported to be associated with 5 
mutations in the H/ACA snoRNP complex.  6 
 7 
Given the large number of the patients with H/ACA snoRNP complex-related disorders and the >70 8 
identified DKC1 mutations, the finding of a novel phenotype related to the H/ACA snoRNP complex might 9 
seem unexpected. However, none of the previous DKC1 mutations affect the highly conserved 10 
pseudouridylation catalytic site and instead affect the N- and C-terminal dyskerin residues which show low 11 
conservation or are even absent in the Pyrococcus furiosus ortholog, Cbf5 (29). Given the fundamental role 12 
of the H/ACA snoRNP complex in development, reflected by the early lethality of the knockout animal 13 
models (26, 32, 33), alongside the lack of missense variants affecting the dyskerin catalytic site, or of DKC1 14 
and NOP10 loss-of-function mutations in patients with telomeropathies, a severe phenotype related to 15 
disrupted pseudouridylation seems likely. This is corroborated by the pseudouridylation defect in DKC1-16 
deficient cells (4), but no significant defect in DC (4, 18, 42). 17 
 18 
We believe that the novel phenotype we describe is the first recorded example of that more severe case. 19 
Although at present we only describe two families, the causality of these mutations has strong support in: 20 
1) the significant LOD scores; 2) the size of the DKC1 family allowing for the genetic tracing of the germline 21 
mosaic, de novo p.Glu206Lys mutation for three generations prior to the index case; 3) the well 22 
characterised role of both mutated amino acids in the interaction of DKC1 and NOP10 (29); and 4) the 23 





shared functional pathophysiology of telomere shortening. Similar examples of pleiotropy have been 1 
described in the CEP290 (44), PMM2 (45, 46), REN (47, 48) or LMNA (49, 50) genes. Indeed, it is unlikely 2 
that this novel phenotype represents the most severe of the H/ACA snoRNP complex syndromes. Loss-of-3 
function mutations are expected to result in an even more severe, potentially in-utero lethal disorder, 4 
making the pleiotropy of the H/ACA snoRNPs even more pervasive. 5 
 6 
Although telomere shortening was apparent, the disorder was lethal before the potential appearance of 7 
classic DC symptoms. Since the dkc1 mutant zebrafish recapitulated the human phenotype with normal 8 
telomere length but ribosomal dysfunction, consequence of impaired 18S rRNA pseudouridylation, a 9 
feature also observed in the patients, we conclude that a pseudouridylation defect is the principal driver 10 
of this novel phenotype. Given the fundamental role of H/ACA snoRNP complex in targeting uridines not 11 
just in rRNAs but also in snRNAs and mRNAs (1, 4, 51, 52), the varied site-specific impact felt on each 12 
uridine residue (34) and the additive consequences of the altered dyskerin-NOP10 interaction we describe, 13 
this phenotype may culminate from a pseudouridylation defect implicating multiple RNAs. There is 14 
increasing evidence for the broader pathogenicity of defective RNA processing in human pathologies (53). 15 
Mutations in the KEOPS-complex, involved in the modification of tRNAs, have recently been identified in 16 
Galloway-Mowat syndrome (54) and a role for defective rRNA methylation has now been described in DC 17 
(55). The findings presented here propose that defective pseudouridylation is a new mechanism for injury 18 
in the human kidney, eye and cochlea, adding to our understanding of RNA processing in human disease.   19 





Materials and methods 1 
 2 
Identification of the causal mutations 3 
All patients or their legal representatives gave written informed consent and the study was approved by 4 
the Local Research Ethic Committees (TUKEB 1154/0-2010-1018EKU and 05/Q0508/6). For Family A 5 
(FamA), linkage analysis was performed using the Human Mapping 250k NspI array (Affymetrix) and 6 
parametric LOD scores were calculated with Multipoint Engine for Rapid Likelihood Interference software 7 
(56), assuming X-linked inheritance. Females with an uncertain phenotype in generation IV were not 8 
included in the linkage analysis. Extended haplotype analysis using five microsatellite markers (DXS8011, 9 
DXS8103, DXS8061, DXS8087, DXS1073) flanking the DKC1 locus was performed in all the available 10 
members of FamA. PCR products with fluorescent primers were separated by capillary electrophoresis 11 
(3130 Genetic Analyzer) and analyzed using GeneMapper analysis software (Life Technologies). 12 
In the affected individual IV:14 and the haploidentical but unaffected individual II:9 of Family A, 13 
enrichment of the linkage interval (Xq28–Xqter:150,474,451–155,270,560 bp; GRCh37/hg19) and 14 
subsequent sequencing were performed as described elsewhere (57). In brief, we used the Roche 15 
NimbleGen 385K custom sequence capture array with a capacity of up to 5 Mb of target sequence. The 16 
exon-based design included all exons of the protein-coding genes, including 100bp of flanking intron 17 
sequence and 1 kb of the promoter regions and known miRNAs within the critical interval. Final coverage 18 
of the design was 99.2%. Enrichment factors of >700-fold were achieved for the two samples. From the 19 
enriched DNA samples, we generated paired-end libraries and sequenced them on an Illumina GA IIx 20 
device with a read length of 2 x 36 bp. The average coverage of the 447,699 bp of target sequences was 21 
>360x in both samples. For data handling and analysis, we used our in-house database and analysis tool 22 
kit VARBANK 2.0 (https://varbank.ccg.uni-koeln.de/varbank2/) with default settings for variant filtering. 23 





These parameters guarentee to focus on rare high-quality variants altering the protein sequence or 1 
showing impairments of splice and translation initiation sites. Only one such variant was found in the 2 
affected individual that was absent from the unaffected one, namely DKC1:c.616G>A, p.Glu206Lys. The 3 
median of 31 pathogenicity rank scores calculated for this variant was 0.83, thus, strongly supporting 4 
causality. The segregation of the DKC1 variant was validated by Sanger sequencing.  5 
 6 
For Family B (FamB), whole exome sequencing of the first index patient (V:2) was conducted by GOSgene 7 
(BGI), from genomic DNA (gDNA) extracted from peripheral blood; exome capture was performed using 8 
the Agilent SureSelect v4 (51 Mb). Homozygosity mapping of candidate variants was conducted on index 9 
patients (V:2 and IV:3), parents and siblings via Sanger sequencing. Segregation analysis confirmed an 10 
autosomal recessive mode of inheritance for a mutation in NOP10 (c.47C>T, p.Thr16Met). This was 11 
confirmed through linkage analysis using the Cyto SNP Microarray technique and Infinium assay HD Ultra 12 
kit (Illumina, #WG-901-4007). Sequencing files were assembled in Genome Studio and regions of shared 13 
homozygosity analysed in Homozygosity Mapper. 14 
 15 
Telomere length analysis 16 
Three independent methods were used to assay the length of the telomeres: Southern blot, MM-qPCR 17 
and flow-fluorescence in situ hybridization (FISH) (SI Appendix). 18 
 19 
X-inactivation measurements 20 
RNA was isolated from peripherial blood (NucleoSpin RNA Blood, Macherey-Nagel), skin and fibroblasts 21 
(Total RNA Mini Kit Tissue, Geneaid) and was reverse transcribed (BIO-65042, Bioline; K1671, Thermo 22 
Scientific) following the manufacturer’s instructions. The X-inactivation ratio was assessed by allele-23 





specific qPCR using a Taqman probe (LightCycler TaqMan Master, Roche, Table S1). A dilution series of 1 
Flag-tagged WT and E206K DKC1 plasmids were used for standardization; all measurements were 2 
performed three times.  3 
 4 
Homology modeling and Molecular Dynamics simulations 5 
Homology models for the WT and mutant H/ACA snoRNP complexes were constructed based on full and 6 
partial H/ACA sRNPs from Pyrococcus furiosus and Saccharomyces cerevisiae (PDB id: 3hay (58); 3hjw (59); 7 
3lwq (60); 2lbw (61); 3u28 (62)) using Schrödinger Modeling Suite (63) and then subjected to 600 ns 8 
molecular dynamics simulations using GROMACS (64), with the AMBER-ff99SBildnp* forcefield (65) and 9 
the parametrization of Steinbrecher et al (66) for the phosphate moieties. The simulations were solvated 10 
by approximately 35880 OPC water molecules (67), the total charge of the system was neutralized and 11 
physiological salt concentration was set using Na+ and Cl- ions. Energy minimization of starting structures 12 
was followed by relaxation of constraints on protein atoms in three steps, with an additional NVT step (all 13 
of 200 ps) to stabilize pressure. Trajectories of 600 ns NPT simulations at 325K (to enhance sampling) and 14 
1 bar were recorded for further analysis (collecting snapshots at every 4 ps). Clustering of the equilibrium 15 
trajectory was carried out based on the backbone structure of the interaction surface of dyskerin and 16 
NOP10 (containing the entire NOP10 model and residues of dyskerin that have an atom reaching within 6 17 
Å of NOP10) using a 1 Å cutoff. 18 
 19 
Generation of dyskerin and NOP10-coding plasmids 20 
The pRSF_DKC1 construct encoding WT human dyskerin has been described previously (28). A Flag-tag 21 
was inserted to produce an N-terminal fusion protein. The Flag-dyskerin encoding cDNA was cloned into 22 
the EcoRI-NotI sites of pcDNA 3.1 Zeo (+) vector. A GFP-tagged human NOP10 encoding vector (Origene, 23 





#NM_018648) was used for co-immunoprecipitation analysis. To produce NOP10 for pressure tuning 1 
fluorescence spectroscopy measurements, the NOP10-encoding cDNA was cloned into pcDNA3.1/V5-His-2 
TOPO (Thermo Fisher Sc.) at the HindIII-XhoI sites to produce NOP10-V5-His. The DKC1 c.616 G>A and the 3 
NOP10 c.47C>T mutations were generated by site-directed mutagenesis (QuikChange II Site-Directed 4 
Mutagenesis Kit (Agilent, #200518)). All primers are listed in Table S1. All constructs were verified by 5 
Sanger sequencing. 6 
 7 
Expression of dyskerin and NOP10 variants 8 
Human embryonic kidney cells (HEK293) were grown at 37°C, 5% CO2 in DMEM media and 10% FBS (Gibco, 9 
Thermo Fisher) and 1% penicillin/streptomycin (P/S) (Gibco, 15140122) as previously described (68). For 10 
pressure tuning fluorescence spectroscopy measurements, cells were transiently transfected using 11 
CalPhos Mammalian Transfection Kit (Clontech) with vectors encoding Flag-tagged dyskerin or V5-tagged 12 
NOP10 variants. For co-immunoprecipitation analysis, cells were transfected with Flag-tagged dyskerin or 13 
GFP-tagged NOP10 variants using polyethylenimine (PEI). A control plate was sham-transfected with PEI 14 
and DPBS. Cells were incubated for 48h post transfection in both experiments.  15 
 16 
Analysis of the subcellular localization of dyskerin 17 
A human immortalized podocyte cell line (AB8/13) provided by M. Saleem (University of Bristol, UK) was 18 
cultured on type I collagen–coated coverslips and transfected with plasmids encoding Flag-tagged WT, 19 
p.Glu206Lys, dyskerin using FuGENE HD according to the manufacturer’s instructions (Promega FUGENE 20 
HD Transfection reagent, E2311, Thermo Fisher Sc.) and incubated for 48 hrs. Transfected podocytes were 21 
fixed in ice cold 4% PFA/100% ethanol for 5 minutes, blocked with PBS-BSA 1% for 15 minutes, incubated 22 
with rabbit anti-flag primary antibodies (F2555, Sigma-Aldrich, 1:500) for 1 hour, followed by Alexa Fluor 23 





647 conjugated goat anti-rabbit IgG secondary antibodies (A-21235, Life Technologies, 1:200) and Alexa 1 
Fluor 555 phalloidin (A34055, Life Technologies, 1:200) both for 1 hour; all conducted at room 2 
temperature. Nuclei were stained with Hoechst. Confocal optical slices were captured using a 40× oil 3 
objective lens (Leica Microsystems), an optical slice thickness of 800 nm and an x-y pixel size of 86 nm 4 
(Leica SP8 confocal microscope, Necker Imaging Facility). 5 
 6 
Co-immunoprecipitation studies 7 
Total protein was harvested using Pierce™ IP Lysis Buffer (Thermo Fisher, #87787) and protein 8 
concentration was determined using the BCA Protein Assay Kit (Thermo Fisher, #23225). One mg of protein 9 
lysate was incubated with 4 ug of target antibody for 8 hours at 4°C, followed by an overnight incubation 10 
with Dynabeads™ Protein G (Thermo Fisher, #10003D). Immunoprecipitated samples were subject to 11 
immunoblot, signal was detected using Pierce™ ECL Western Blotting Substrate (Thermo Fisher, #32106). 12 
In addition, primary keratinocytes were isolated from skin biopsy and cultured as described in Nowak et 13 
al (69). Co-immunoprecipitation studies were conducted as described above with the amendment of 500 14 
ug of protein lysate, 2ug of NOP10 antibody (Abcam, #ab134902) and host-specific Sheep Anti-Rabbit IgG 15 
Dynabeads™ (Invitrogen, #11203D).   16 





Protein extraction for pressure tuning fluorescence spectroscopy 1 
Total protein was harvested by 150 mM NaCl, 20 mM Tris, 1% Triton-X supplemented with 0.1% protease 2 
inhibitor (Protease Inhibitor Cocktail, Sigma-Aldrich). Lysates were incubated with monoclonal anti-flag 3 
(F3165, Sigma Aldrich) or anti-V5/NOP10 (ab182008/ab134902, Abcam) antibodies) and subsequently 4 
with Protein G beads (Dynabeads Protein G for Immunoprecipitation, Thermo Fisher Scientific). Dyskerin 5 
and NOP10 variants were eluted by competition with Flag and V5 peptides (B23111, B23511, Biotool; 6 
F3290, Sigma Aldrich) for 30 minutes, repeated 5 times. Eluate concentration was measured by 7 
spectrophotometry (DC Protein Assay, Bio-Rad) and verified by SDS-PAGE, using anti-V5/anti-NOP10 8 
(F3165, Sigma Aldrich, ab182008/ab134902, Abcam) as primary and anti-mouse/anti-goat IgG-HRP as 9 
secondary (sc-2005, sc-2357, SCBT) antibodies.  10 
 11 
Pressure tuning fluorescence spectroscopy 12 
Pressure tuning fluorescence spectroscopy was used to determine the dissociation constant of the NOP10-13 
dyskerin complex (Kd) and the pKd (pKd = -log(Kd)) (70, 71) as well as the volume change accompanying 14 
dissociation (ΔV, ml/mol). Briefly, the method involves the use of a fluorescent dye which binds to the 15 
solvent-accessible, hydrophobic regions of proteins, hydrostatic pressure is then varied to induce 16 
dissociation. By fitting a dissociation model to the fluorescence data, the Kd and ΔV values are determined 17 
as follows: 18 















Where I(p) and I0 are the resulting and original fluorescence intensities, respectively, ΔI is the maximal 20 
intensity change and C is the total protein concentration. This method yields a specific volume and by 21 
determining the width of pressure range in the 5%-95% dissociation regime, structural heterogeneity was 22 





qualitatively assessed. A nonlinear least squares was fitted to the data and statistical difference between 1 
WT and mutant complexes was assessed via a Welch-test (Statistica 13.4). The interaction surface was 2 
directly related to the pKd through the general concept of the equilibrium constant: 3 
𝐾 = 𝐴 ∙  𝑒−
∆𝐸
𝑘𝑇 = 𝐴 ∙ 𝑒−
𝑎∗𝑆+𝑏
𝑘𝑇  4 
Where ΔE is the complex formation energy, A is the pre-exponential factor, S is the interaction surface in 5 
Ångström (Ǻ) and a, b are the parameters of the linear function connecting ΔE and S.  6 
 7 
Generation of zebrafish mutants 8 
CRISPR/Cas9 mediated mutagenesis of the dkc1 gene was carried out in the WT tuebingen (tue) strain as 9 
previously described (72); targeted regions (gRNA sequences) are listed in Table S1. Genotyping was 10 
conducted using PCR on gDNA samples isolated from fin clips; the allele-specific forward primers for 11 
genotyping, sequencing of exon 7 and 11 and exon-specific reverse primers are listed in Table S1. An anti-12 
sense, translation-blocking morpholino (MO) was ordered from GeneTools (Portland, OR) to confirm 13 
specificity of the null elu1 and elu8 phenotype. WT (tue) and mutant dkc1 and tp53 fish lines were 14 
maintained in the animal facility of ELTE Eötvös Loránd University according to standard protocols (73, 74). 15 
All zebrafish protocols were approved by the Hungarian National Food Chain Safety Office (Permit 16 
Number: XIV-I-001/515-4/2012) and the Pest County Governmental Office (Permit Number: PE/EA/2023-17 
7/2017). 18 
 19 
Zebrafish rescue experiments 20 
The CDS for human DKC1 and DKC1 E206K were cloned into a pCS2+ vector, linearized with KpnI and in 21 
vitro transcribed using the mMessage mMachine SP6 kit (Ambion). Zebrafish embryos from a dkc1elu1/+ in-22 
cross were injected with DKC1 mRNA at 1-2 cell stage and phenotypically scored at 4 dpf.  23 






Zebrafish histology 2 
In situ hybridization experiments, Neutral Red and hematoxylin-eosin histological stainings, 3 
immunostaining, Acridin Orange labeling and filtration tests using fluorescent dextrans were performed 4 
according to standard protocols (SI Appendix). 5 
  6 
Zebrafish growth measurements 7 
Offspring of incrossed dkc1elu2/+ heterozygous fish were housed and raised at standard stocking densities. 8 
Measurements were taken at four months of age. Body length was measured as standard length, from the 9 
tip of the head to the end of the trunk and wet body weight was determined using a standardised method 10 
(75), to avoid anesthesia.  11 
 12 
Analysis of 28S/18S rRNA ratio and pseudouridylation 13 
Total RNA was isolated from 4.5-5 dpf zebrafish by TRIzol Reagent (Invitrogen). The RNA quality was 14 
assessed on Agilent 2100 Bioanalyzer using the RNA 6000 Pico kit (Agilent Technologies) according to the 15 
manufacturers’ instructions. For comparison of 18S and 28S rRNA abundance in mutant and WT fish, 16 
densitometry of the 18S and 28S peaks was performed using ImageJ and their ratio was compared by 17 
Student’s t-test (Statistica software version 13.2). 18 
 19 
Pseudouridylation was assessed by immuno-northern blotting as previously described (76). In brief, 3 g 20 
of total RNA was loaded per well on a 1.5% denaturing agarose gel and imaged to assess for degradation. 21 
Gel blotting was performed overnight onto a nylon membrane (Amersham HybondN -GE Healthcare Life 22 
Sciences), followed by UV cross-linking. Nylon membranes were blocked with 5% non-fat milk for 1 hour, 23 





then incubated with an anti-pseudouridine (D-347-3, MBL, dil. 1:500 in PBS) primary antibody for 1.5 1 
hours, followed by an HRP-conjugated anti-mouse IgG (sc -2005, SCBT, dil. 1:1000 in PBS) secondary for 1 2 
hour, all at room temperature. Bands were visualized by chemiluminescence (Western Blotting Luminol 3 
Reagent, sc-2048, SCBT) on Molecular Imager VersaDoc MP 5000 System (Bio-Rad). Densitometry was 4 
performed using ImageJ processing program. Experiments were repeated three times. To assess the 18S 5 
rRNA pseudouridylation, the ratio of the normalized 18S rRNA PU and the normalized 18S rRNA was 6 
compared between the mutant and the sibling zebrafish by Mann-Whitney U test. 7 
 8 
Whole transcriptome analysis 9 
Total RNA was extracted from whole zebrafish embryos at 36 hpf, using TRIzol reagent (Thermo Fisher, 10 
15596018) and three biological replicate samples were prepared for mutants and siblings, respectively. 11 
The samples were sequenced on Illumina MiSeq platform by Microsynth (Microsynth AG, Switzerland) 12 
according to standard lllumina protocols. Raw sequence data was deposited to the Sequence Read Archive 13 
(SRA), accession number PRJNA548449. Raw reads were pre-processed with FASTQC (77), followed by 14 
analysis based on the ’new tuxedo pipeline’ (HISAT, StringTie and Ballgown) using default settings (78). 15 
Gene ontology term analysis and visualization was performed using the emapplot function of the 16 
clusterProfiler package (79). 17 
 18 
Western blot of dyskerin and p53 in zebrafish 19 
For the Western blotting of both dyskerin and p53 n = 12 dkc1+/? and n = 12 dkc1elu1/elu1 5 dpf embryos were 20 
used. Protein extraction was performed following standardised protocols (80). Whole lysates were loaded 21 
on 4–20% MiniPROTEAN® TGX StainFree™ Protein Gel and transferred to a Trans-Blot®Turbo™ Mini 22 
Nitrocellulose membrane (Bio-Rad). Membranes were blocked with 5% non-fat milk in PBS and were 23 





incubated with dyskerin antibody (H-300, SCBT) or anti-p53 antibody (ab77813, Abcam) as primary 1 
antibodies in PBS - 0.1% Tween-20 and goat anti-rabbit IgG-HRP as secondary antibody (sc-2004, SCBT). 2 
Gamma tubulin antibody (T5326, Sigma-Aldrich) was used as a loading control. Proteins were visualized 3 
by chemiluminescence (Western Blotting Luminol Reagent, sc-2048, SCBT) and densitometry was 4 
performed on Molecular Imager VersaDoc MP 5000 System (Bio-Rad). 5 
 6 
Cycloheximide (CHX) treatments 7 
CHX was used to impair translation in developing zebrafish embryos as previously described (35). In brief, 8 
WT zebrafish embryos were treated in 10 M CHX (Sigma-Aldrich, C7698) from 36 hpf, the first time point 9 
when the mutant phenotype of dkc1elu1/elu1 embryos becomes apparent. 10 
 11 
Determination of pseudouridine and uridine content via HPLC-MS 12 
RNA was isolated from peripherial blood (NucleoSpin RNA Blood, Macherey-Nagel) and skin (Total RNA 13 
Mini Kit Tissue, Geneaid) and their pseudouridine and uridine content were measured as described 14 
previously (81). Briefly, for the determination a HPLC-MS/MS system was used including an Agilent 1100 15 
modular HPLC (Agilent Technologies, USA) and an MDS Sciex API 4000 Triple-Quad mass spectrometer 16 
(Applied Bioscience, USA) equipped with the TurboV-Spray source. For the gradient elution on the 17 
Phenomenex Luna C18, 5 μm 3.0 x 150 mm column (Gen-Lab, Hungary), water (A) and mixture of water 18 
and methanol (50 V/V%, B) were used, supplemented both with ammonium acetate (25 mM). At the initial 19 
stage of the separation the B was kept at 0% for 1 minute and increased up to 100% for 5 minutes, which 20 
was hold for 3 minutes before the column equilibration. The flow rate was 400 μl/min and the column was 21 
thermostated at 55°C. For the detection, the mass spectrometer operated in the positive mode, where the 22 
ESI ion source gas temperature was set at 525°C, the ionisation voltage at 5000 V. During the multiple 23 





reaction monitoring measurements, the precursor ion was set to m/z 245.2 while the monitored fragment 1 
ion was m/z 113.1 using 50 V and 20 eV for the declustering potential and collision energy, respectively.  2 
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Table 1. Clinical characteristics of the affected family members 1 
Pt (sex) 
visual inv  
(age at 1st cat 
surgery) 
hearing impairment 
(age at HA) 
nephrotic 
syndrome 
(age at pres) 
enterocolitis 
(age at pres) 
other 
Age at last 
follow-up/ 
death (†) 
Fam A       
II:1 (M) cat nd + + (infancy) FTT † 3 yrs 
II:3 (F) - + - - - 60 yrs 
II:8 (F) glau + - - - 58 yrs 
III:1 (M) cat nd + + (6 mos) BMF † 2.5 yrs 
III:3 (F) cat (16 yrs), RP + (17 yrs) - - 
HK, Mand, 
Max, MO, FTT 
48 yrs 
III:6 (F) cat (14 yrs) + (8 yrs) - - 
CA, Mand, 
Max, PH, FTT 
40 yrs 
III:8 (F) cat (17 yrs) + (10 yrs) - - FTT 45 yrs 
III:11 (M) nd + + + (6 mos) FTT † 4.5 yrs 
IV:1 (M) cat (2 yrs) + (2 yrs) + (>2 yrs) + - † 2.5 yrs 
IV:4 (F) cat (4 yrs), RP + (1.5 yrs) + (2 yrs) - 
CA, MO, PH, 
FTT 
15 yrs 
IV:6 (M) cat (6 mos) + (6 mos) + (2.5 yrs) + (6 mos) BMF, FTT † 2.5 yrs 
IV:9 (F) - - - - - 20 yrs 
IV:12 (F) cat (10 yrs), RP + PU (10 yrs) - - 11 yrs 
IV:14 (M) cat (3 yrs) + (3.5 yrs) 
+ (2.5 yrs) 
FSGS 
+ (5 yrs) BMF, FTT † 7.5 yrs 
IV:15 (F) - - - - - 15 yrs 
Fam B       
IV:3 (F) cat + (birth) + FSGS +  † 3 yrs 
V:2 (F) cat + (birth) + MPGN + CH, HM † 3 yrs 
BMF: bone marrow failure, CA: mild cerebellar atrophy, cat: cataracts, CH: cerebellar hypoplasia, F: female, 2 
FSGS: focal segmental glomerulosclerosis, FTT: failure to thrive, glau: glaucoma, HA: indication of hearing 3 
aid, HK: hyperkeratosis, HM: hypomyelination, inv: involvement, M: male, mos: months, Mand: 4 
mandibular hypoplasia, Max: maxillary hypoplasia, MO: microphthalmia, MPGN: mesangial proliferative 5 
glomerulonephritis, nd: no data available, PH: pineal hypoplasia, pres: presentation, PU: non-nephrotic 6 
proteinuria, RP: retinitis pigmentosa, yrs: years 7 





Figure 1. Phenotype and genetic identification of the two affected families 1 
Affected (a) males (n=6) and (b-c) females (n=9) in FamA had no dysmorphic features apart from maxillary 2 
and mandibular hypoplasia in adult females. Affected males in FamA (a, v) and the two affected females 3 
(n=2) from the consanguineous FamB (x) developed nephrotic syndrome with focal segmental 4 
glomerulosclerosis (m, o), diffuse podocyte foot process effacement (n) and enterocolitis with extensive 5 
chronic nonspecific inflammation (p-r). FamB, Patient V:2, developed progressive hypomyelination (i) and 6 
cerebellar hypoplasia (l), both IV:3 and V:2 passed away in infancy. Cataracts (d, e) and sensorineural 7 
hearing impairment with a modiolus (s: black arrow, u), cochlea (t: white arrow, u) and cochlear nerve (s, 8 
t: white arrow) of normal morphology were present, even in the affected females of FamA, who had a 9 
normal lifespan and developed pigmentary retinopathy (g-h), microphthalmia (f) and pineal hypoplasia (j-10 
k, Figure S2). We found linkage to a 5.1 Mb region at Xq28 in the descendants of II:3 (w), assuming germline 11 
mosaicism in I:2 (v) with a LOD score of 3.01. Through targeted sequencing in an unaffected and an 12 
affected but haploidentical male (II:9 and IV:14), we found a single de novo mutation in DKC1 (c.616 G>A, 13 
p.Glu206Lys), which segregated among the six haploidentical members in the generation II with disease 14 
occurrence (v). Homozygosity mapping in FamB (x) showed a haploidentical homozygous region of 2.6 Mb 15 
at 15q14 with a LOD score of 3.03 (y). Exome sequencing of patient V:2 and targeted segregation analysis 16 
of IV:3 and V:2, parents and siblings revealed a homozygous missense mutation in NOP10 (c.47C>T, 17 
p.Thr16Met).  18 





Figure 2. Absent or subtle symptoms of Dyskeratosis Congenita despite telomere shortening 1 
We found telomere shortening in the affected individuals by (a) Southern blot (heterozygous individuals 2 
in FamA and affected individuals in FamB are in bold), (b) showing a significant difference between the 3 
severely affected children (FamA, IV:4, IV:14, FamB IV:3, V:2) and six age-matched controls (p = 0.038). 4 
Telomere attrition was also shown by (c) MM-qPCR and (d-f) Flow-FISH. (g) The severely affected index 5 
female (FamA, IV:4) showed a highly skewed X-inactivation in the fibroblasts and skin, with the ratio of her 6 
PBMCs expressing the mutant DKC1 allele decreasing with age. FB: fibroblast; blue:E206K, red:wt DKC1 7 
mRNA. (h) Despite telomere shortening, no nail dystrophy or leukoplakia was observed, with one 8 
heterozygous female from FamA (III:3) and one female from FamB (V:2) being diagnosed with mild 9 
dyskeratosis after genetic diagnosis. ys: years  10 





Figure 3. Dyskerin p.Glu206Lys and NOP10 p.Thr16Met mutations alter the pseudouridylation pocket of 1 
the H/ACA snoRNP complex 2 
(a) Homology modelling of human H/ACA snoRNP dyskerin (amino acids 60-380), grey; NOP10, green; 3 
GAR1, red; NHP2, yellow; guide snoRNA, dark blue; substrate RNA, light blue. The Glu206 (dyskerin) and 4 
Thr16 (NOP10) are in CPK format (carbon atoms are shown in the colour of the backbone, oxygen in red 5 
and nitrogen in blue). The C-alpha atoms of residues associated with Dyskeratosis Congenita and Hoyeraal-6 
Hreidarsson syndrome are shown in spheres. (b) Co-Immunoprecipitation of native dyskerin from HEK293 7 
cells transfected with GFP-tagged WT and T16M NOP10 and reciprocal immunoprecipitation of native 8 
NOP10 from HEK293 cells transfected with Flag-tagged WT and E206K dyskerin. Immunoblots show that 9 
both mutant proteins immunoprecipitate with their native counterpart (see also Figure S4). (c-d) Pressure-10 
tuning fluorescence spectra of WT and mutant dyskerin-NOP10 complexes, where mutant complexes 11 
show an altered stability. (e) Structural heterogeneity indicates significant structural difference between 12 
mutants and WT (Welch-test: DKC1, p = 1.8x10-2; NOP10 p = 4.04×10-11). (f) Disassociation constants of WT 13 
and mutant complexes show both mutations cause a parallel change in pKd (left, Welch-test: DKC1, p = 14 
9.54×10-3; NOP10, p = 1.55 × 10-7) and the interaction surface (right). (g-h) Conformational changes induced 15 
by the mutations (g) WT dyskerin Glu206 interacts with the NOP10 Thr16-Leu17-Lys18 segment forming 16 
hydrogen-bonds (left), these H-bonds are disrupted by both the dyskerin E206K (middle) and NOP10 T16M 17 
(right) mutations. (h) The WT interaction (left) between the substrate uridine and the catalytic D125 of 18 
dyskerin is uncoupled by both dyskerin E206K (middle) and NOP10 T16M (right). IP, immunoprecipitated 19 
protein; S, supernatant; CNTL, cells transfected with empty expression plasmid, expressing GFP-Flag, size 20 
of 28kDa; HEK293, non-transfected cells; and 1°, primary antibody. Statistical significance denoted by 21 
asterisks.  22 





Figure 4. The phenotype of dkc1elu1/elu1 larvae recapitulates the human phenotype  1 
(a) Histological analysis of dkc1elu1/elu1 mutant larvae shows microphthalmia and cataracts. Both the eyes 2 
and the optic tectum of the mutants are abnormal and contain a high prevalence of cells with 3 
neuroepithelial character. Expression of cell-cycle markers ccnD1 and PH3 in the retinae and the tecta of 4 
2 dpf and 3 dpf larvae, respectively, can be observed throughout these tissues instead of being restricted 5 
to the proliferative regions of the ciliary marginal zone and the mediolateral edges, suggesting defective 6 
cell cycle. (All pictures show coronal sections.) (b) Further histological analysis shows i) deformed 7 
semicircular canals, ii) undifferentiated gut iii) and hypoplastic pronephros with a reduced number of WT1-8 
positive podocytes in the mutant animals (scale bar = 10 m). (c) When Dkc1-function is abrogated in 9 
Tg(foxd3:EGFP) animals using a synthetic MO oligo, parapineal migration is impaired and the pineal-10 
parapineal complex appears immature at 3 dpf. (White arrows denote the parapineal). (d) Markers of 11 
tissue differentiation demonstrate a lack of differentiation in the intestines (ifbp), pancreas (try) and the 12 
major blood lineages (gata1 and rag1). (Black arrows denote area of expression.) (e) Injection of i) human 13 
WT DKC1 mRNA resulted in phenotypic rescue of the mutant larvae, as shown by the genotyping of larvae 14 
showing a WT phenotype. In contrast, injection of ii) human Glu206Lys DKC1 mRNA elicited a much milder 15 
rescue, demonstrating the hypomorphic nature of this allele.   16 





Figure 5. Ribosomal dysfunction in dkc1 zebrafish mutants due to defective pseudouridylation 1 
(a) Telomere length is normal in dkc1elu1/elu1 larvae at 4dpf as measured by flow-FISH (n = 3 pooled samples 2 
of 10 larvae each, p = 0.7). (b) The 28S/18S rRNA ratio is increased in 4 dpf dkc1elu1/elu1 larvae, suggesting 3 
impaired 18S rRNA processing (p = 0.0033).(c-d) Immunonorthern-blot demonstrates a reduced 4 
pseudouridylation of 18S rRNA in dkc1elu1/elu1, dkc1elu8/elu8 4 dpf larvae (+/? vs. elu1/elu1: p = 0.016, +/? vs. 5 
elu8/elu8: p = 0.00058) (c) and in the leukocytes of patient FamB IV:3 (d). (+/?: heterozygous or 6 
homozygous WT fish). (e) The female with skewed X-inactivation shows a decreased PU/U ratio in the 7 
leukocytes as determined by HPLC-MS. (f) Gene ontology analysis of differentially regulated genes from 8 
36 hours post fertilization (hpf) dkc1elu1/elu1 larvae demonstrates an upregulation of genes associated with 9 
ribosome assembly and function. Size of the circles indicate the number of genes associated with certain 10 
terms, color indicates the level of enrichment: red indicates high enrichment, blue indicates low. (g) 11 
Western blot suggests the stabilisation of Tp53 in the affected cells. (h) Transcriptomic analysis shows that 12 
the truncated, anti-apoptotic tp53 isoform (Ä113p53) is upregulated in mutants, while the canonical, full-13 
length, pro-apoptotic isoform shows decreased expression; measured as FPKM. (i) The phenotype of the 14 
dkc1elu1/elu1 zebrafish mutants is Tp53 independent, as it is not rescued on a tp53- background. (j) 15 
Homozygous carriers of the missense (c.567_568insGTG) hypomorphic allele (dkc1elu2/elu2) are viable, but 16 
show significant growth retardation compared with their siblings (n = 130) (+/+ vs. elu2/elu2: p = 1.9 x 10-17 
9, +/elu2 vs. elu2/elu2: p = 1.6 x 10-9). 18 
